International Clinical Trial: A Single-center, Single-arm, Exploratory Phase II Clinical Trial of Irreversible Electroporation Combined with First-line Chemotherapy for Pancreatic Cancer with Liver Oligometastases

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2600115939) titled 'A Single-center, Single-arm, Exploratory Phase II Clinical Trial of Irreversible Electroporation Combined with First-line Chemotherapy for Pancreatic Cancer with Liver Oligometastases' on Jan. 4.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Sun Yat-sen University Cancer Center

Condition: Pancreatic cancer

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-01-04

Target Sample Size: Experimental Group:50;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=298983

Published by HT Digital Content Servi...